A. Avramovska

Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort

F. Houssiau, P. Durez, B. Lauwerys, 2020, Arthritis Research & Therapy.

Should we use glucocorticoid in Early Rheumatoid Arthritis?: Results at 5 years from the ERA UCLouvain Brussels cohort.

P. Durez, S. Dierckx, T. Sokolova, 2021, Rheumatology.

Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort

P. Durez, S. Dierckx, T. Sokolova, 2022, Rheumatology and Therapy.

Lung involvement in early rheumatoid arthritis, interim analysis of the FINDRA prospective study

P. Durez, B. Ghaye, M. Doyen, 2022, 12.02 - ILD/DPLD of known origin.

Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort

P. Durez, S. Dierckx, T. Sokolova, 2023, Rheumatology and Therapy.

AB0169 EARLY REMISSION AT 6 MONTHS AS A PREDICTOR OF LONGTERM REMISSION IN NEW ONSET RHEUMATOID ARTHRITIS

M. Malaise, P. Durez, C. Ribbens, 2022, Annals of the Rheumatic Diseases.